HomeSLS • NASDAQ
Sellas Life Sciences Group Inc
add
$2.17
2.36%
After Hours:(0.014%)+0.00030
$2.17
Closed: Jul 3, 5:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.06M | -37.14% |
Net income | -5.81M | 39.23% |
Net profit margin | — | — |
Earnings per share | -0.07 | 66.67% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 28.40M | 54.21% |
Total assets | 34.96M | 43.06% |
Total liabilities | 7.20M | -51.21% |
Total equity | 27.76M | — |
Shares outstanding | 99.78M | — |
Price to book | 6.84 | — |
Return on assets | -55.74% | — |
Return on capital | -77.54% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -5.81M | 39.23% |
Cash from operations | -9.07M | 15.71% |
Cash from investing | — | — |
Cash from financing | 23.58M | -11.50% |
Net change in cash | 14.51M | -8.65% |
Free cash flow | -7.06M | 3.79% |
Previous close
$2.12
Day range
$2.12 - $2.20
Year range
$0.77 - $2.27
Market cap
216.52M USD
Avg Volume
3.38M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2006
Website
Employees
15
